GXMC
ACAD icon

Global X Management Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Global X Management Company’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$30K Buy
1,963
+257
+15% +$4.58K ﹤0.01% 1161
2018
Q1 		$38K Buy
1,706
+424
+33% +$11.7K ﹤0.01% 1056
2017
Q4 		$39K Buy
1,282
+305
+31% +$9.75K ﹤0.01% 947
2017
Q3 		$37K Buy
977
+140
+17% +$4.55K ﹤0.01% 967
2017
Q2 		$23K Buy
837
+579
+224% +$17.3K ﹤0.01% 1116
2017
Q1 		$9K Buy
258
+4
+2% +$141 ﹤0.01% 1154
2016
Q4 		$7K Buy
254
+10
+4% +$265 ﹤0.01% 1045
2016
Q3 		$8K Hold
244
– – ﹤0.01% 1031
2016
Q2 		$8K Buy
+244
New +$8.17K ﹤0.01% 899

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return